Screening for Alagille syndrome mutations in the JAG1 and NOTCH2 genes using denaturing high-performance liquid chromatography

被引:8
|
作者
Samejima, Hazuki
Torii, Chiharu
Kosaki, Rika
Kurosawa, Kenji
Yoshihashi, Hiroshi
Muroya, Koji
Okamoto, Nobuhiko
Watanabe, Yoriko
Kosho, Tomoki
Kubota, Michiru
Matsuda, Osamu
Goto, Miwa
Izumi, Kosuke
Takahashi, Takao
Kosaki, Kenjiro
机构
[1] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Childrens Natl Med Ctr, Dept Clin Genet & Mol Med, Tokyo, Japan
[3] Kanagawa Childrens Med Ctr, Div Med Genet, Kanagawa, Japan
[4] Kanagawa Childrens Med Ctr, Div Endocrinol, Kanagawa, Japan
[5] Osaka Med Ctr, Dept Planning & Res, Osaka, Japan
[6] Res Inst Maternal & Child Hlth, Osaka, Japan
[7] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Fukuoka, Japan
[8] Shinshu Univ, Sch Med, Dept Med Genet, Nagano, Japan
[9] Hokkaido Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan
[10] Ehime Univ, Sch Med, Dept Pediat, Matsuyama, Ehime 790, Japan
来源
GENETIC TESTING | 2007年 / 11卷 / 03期
关键词
D O I
10.1089/gte.2006.0519
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in the JAG1 gene and the NOTCH2 gene cause Alagille syndrome. At present, however, genetic testing of Alagille syndrome is not commonly applied in clinical settings because the currently available assays are technically and financially demanding, mainly because of the size of the genes. In the present study, we optimized the highly sensitive and specific mutation scanning method automated denaturing high- performance liquid chromatography (DHPLC) to analyze the entire coding region of JAG1 and NOTCH2. The coding region was amplified by 69 primer pairs, all of which have the same cycling conditions, aliquoted on a 96-well format PCR plate. In this manner, all the exons were simultaneously amplified using a single block in a thermal cycler. We then wrote a computer script to analyze each segment of JAG1 and NOTCH2 by DHPLC in a serial manner using conditions that were optimized for each amplicon. The implementation of this screening method for JAG1 and NOTCH2 will help medical geneticists confirm their clinical impressions and provide accurate genetic counseling to the patients with Alagille syndrome and their families.
引用
收藏
页码:216 / 227
页数:12
相关论文
共 50 条
  • [1] A mouse model of Alagille syndrome:: Notch2 as a genetic modifier of Jag1 haploinsufficiency
    McCright, B
    Lozier, J
    Gridley, T
    DEVELOPMENT, 2002, 129 (04): : 1075 - 1082
  • [2] Clinical and genetic characteristics of patients with Alagille syndrome in China: identification of six novel JAG1 and NOTCH2 mutations
    Chen, Lingli
    Chen, Jie
    Lou, Jingan
    Yu, Jindan
    TRANSLATIONAL PEDIATRICS, 2024, 13 (12)
  • [3] Absence of NOTCH2 and Hey2 mutations in a familial Alagille syndrome case with a novel frameshift mutation JAG1
    El-Rassy, Inaam
    Bou-Abdallah, Jad
    Al-Ghadban, Sara
    Bitar, Fadi
    Nemer, Georges
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2008, 146A (07) : 937 - 939
  • [4] Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification
    Gilbert, Melissa A.
    Bauer, Robert C.
    Rajagopalari, Ramakrishnan
    Grochowski, Christopher M.
    Chao, Grace
    McEldrew, Deborah
    Nassur, James A.
    Rand, Elizabeth B.
    Krock, Bryan L.
    Kamath, Binita M.
    Krantz, Ian D.
    Piccoli, David A.
    Loomes, Kathleen M.
    Spinner, Nancy B.
    HUMAN MUTATION, 2019, 40 (12) : 2197 - 2220
  • [5] Screening for CHARGE syndrome mutations in the CHD7 gene using denaturing high-performance liquid chromatography
    Aramaki, Michihiko
    Udaka, Toru
    Torii, Chiharu
    Samejima, Hazuki
    Kosaki, Rika
    Takahashi, Takao
    Kosaki, Kenjiro
    GENETIC TESTING, 2006, 10 (04): : 244 - 251
  • [6] Exome Sequencing Reveals Compound Heterozygous Mutations in ATP8B1 in a JAG1/NOTCH2 Mutation-Negative Patient with Clinically Diagnosed Alagille Syndrome
    Grochowski, Christopher M.
    Rajagopalan, Ramakrishnan
    Falsey, Alexandra M.
    Loomes, Kathleen M.
    Piccoli, David A.
    Krantz, Ian D.
    Devoto, Marcella
    Spinner, Nancy B.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (04) : 891 - 893
  • [7] Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography
    Atencio, DP
    Iannuzzi, CM
    Green, S
    Stock, RG
    Bernstein, JL
    Rosenstein, BS
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2001, 38 (2-3) : 200 - 208
  • [8] Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography
    Biggin, A
    Henke, R
    Bennetts, B
    Thorburn, DR
    Christodoulou, J
    MOLECULAR GENETICS AND METABOLISM, 2005, 84 (01) : 61 - 74
  • [9] Evaluation of denaturing high-performance liquid chromatography (DHPLC) in the screening of mutations in hemophilia B patients
    Herbert, O
    Trossaërt, A
    Boisseau, P
    Fressinaud, E
    Gerson, F
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (12) : 2267 - 2269
  • [10] Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2)
    Lin, D
    Goldstein, JA
    Mhatre, AN
    Lustig, LR
    Pfister, M
    Lalwani, AK
    HUMAN MUTATION, 2001, 18 (01) : 42 - 51